» Articles » PMID: 21050542

A Computer-aided Diagnosis System for Quantitative Scoring of Extent of Lung Fibrosis in Scleroderma Patients

Overview
Specialty Rheumatology
Date 2010 Nov 6
PMID 21050542
Citations 76
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To evaluate an improved quantitative lung fibrosis score based on a computer-aided diagnosis (CAD) system that classifies CT pixels with the visual semi-quantitative pulmonary fibrosis score in patients with scleroderma-related interstitial lung disease (SSc-ILD).

Methods: High-resolution, thin-section CT images were obtained and analysed on 129 subjects with SSc-ILD (36 men, 93 women; mean age 48.8±12.1 years) who underwent baseline CT in the prone position at full inspiration. The CAD system segmented each lung of each patient into 3 zones. A quantitative lung fibrosis (QLF) score was established via 5 steps: 1) images were denoised; 2) images were grid sampled; 3) the characteristics of grid intensities were converted into texture features; 4) texture features classified pixels as fibrotic or non-fibrotic, with fibrosis defined by a reticular pattern with architectural distortion; and 5) fibrotic pixels were reported as percentages. Quantitative scores were obtained from 709 zones with complete data and then compared with ordinal scores from two independent expert radiologists. ROC curve analyses were used to measure performance.

Results: When the two radiologists agreed that fibrosis affected more than 1% or 25% of a zone or zones, the areas under the ROC curves for QLF score were 0.86 and 0.96, respectively.

Conclusions: Our technique exhibited good accuracy for detecting fibrosis at a threshold of both 1% (i.e. presence or absence of pulmonary fibrosis) and a clinically meaningful threshold of 25% extent of fibrosis in patients with SSc-ILD.

Citing Articles

Extent of lung fibrosis is of greater prognostic importance than HRCT pattern in patients with progressive pulmonary fibrosis: data from the ILD-PRO registry.

Swaminathan A, Weber J, Todd J, Palmer S, Neely M, Whelan T Respir Res. 2025; 26(1):73.

PMID: 40022059 PMC: 11871617. DOI: 10.1186/s12931-025-03136-6.


Biological correlates of radiological features of systemic sclerosis interstitial lung disease.

Volkmann E, Tashkin D, Leng M, Kim G, Goldin J, Harui A ERJ Open Res. 2025; 11(1).

PMID: 39902269 PMC: 11788817. DOI: 10.1183/23120541.00596-2024.


Relationship between high-resolution computed tomography quantitative imaging analysis and physiological and clinical features in antisynthetase syndrome-related interstitial lung disease.

Bae S, Abtin F, Kim G, Markovic D, Chan C, Moghadam-Kia S RMD Open. 2024; 10(4).

PMID: 39608864 PMC: 11603737. DOI: 10.1136/rmdopen-2024-004592.


Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis: The INTEGRIS-IPF Clinical Trial.

Lancaster L, Cottin V, Ramaswamy M, Wuyts W, Gisli Jenkins R, Scholand M Am J Respir Crit Care Med. 2024; 210(4):424-434.

PMID: 38843105 PMC: 11351797. DOI: 10.1164/rccm.202403-0636OC.


From pixels to prognosis: unlocking the potential of deep learning in fibrotic lung disease imaging analysis.

de la Orden Kett Morais S, Felder F, Walsh S Br J Radiol. 2024; 97(1161):1517-1525.

PMID: 38781513 PMC: 11332672. DOI: 10.1093/bjr/tqae108.


References
1.
Uppaluri R, Hoffman E, Sonka M, Hartley P, Hunninghake G, McLennan G . Computer recognition of regional lung disease patterns. Am J Respir Crit Care Med. 1999; 160(2):648-54. DOI: 10.1164/ajrccm.160.2.9804094. View

2.
Xu Y, van Beek E, Hwanjo Y, Guo J, McLennan G, Hoffman E . Computer-aided classification of interstitial lung diseases via MDCT: 3D adaptive multiple feature method (3D AMFM). Acad Radiol. 2006; 13(8):969-78. DOI: 10.1016/j.acra.2006.04.017. View

3.
Karassa F, Ioannidis J . Mortality in systemic sclerosis. Clin Exp Rheumatol. 2008; 26(5 Suppl 51):S85-93. View

4.
Park K, Bergin C, Clausen J . Quantitation of emphysema with three-dimensional CT densitometry: comparison with two-dimensional analysis, visual emphysema scores, and pulmonary function test results. Radiology. 1999; 211(2):541-7. DOI: 10.1148/radiology.211.2.r99ma52541. View

5.
Goldin J, Elashoff R, Kim H, Yan X, Lynch D, Strollo D . Treatment of scleroderma-interstitial lung disease with cyclophosphamide is associated with less progressive fibrosis on serial thoracic high-resolution CT scan than placebo: findings from the scleroderma lung study. Chest. 2009; 136(5):1333-1340. PMC: 2773360. DOI: 10.1378/chest.09-0108. View